BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ashigbie PG, Shepherd S, Steiner KL, Amadi B, Aziz N, Manjunatha UH, Spector JM, Diagana TT, Kelly P. Use-case scenarios for an anti-Cryptosporidium therapeutic. PLoS Negl Trop Dis 2021;15:e0009057. [PMID: 33705395 DOI: 10.1371/journal.pntd.0009057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Basile FW, Fedele MC, Lo Vecchio A. Gastrointestinal Diseases in Children Living with HIV. Microorganisms 2021;9:1572. [PMID: 34442651 DOI: 10.3390/microorganisms9081572] [Reference Citation Analysis]
2 Esmat M, Abdel-aal AA, Shalaby MA, Badawi M, Elaskary H, Yousif AB, Fahmy MA. Efficacy of clofazimine and nitazoxanide combination in treating intestinal cryptosporidiosis and enhancing intestinal cellular regeneration in immunocompromised mice. Food and Waterborne Parasitology 2022;27:e00161. [DOI: 10.1016/j.fawpar.2022.e00161] [Reference Citation Analysis]
3 Pane S, Putignani L. Cryptosporidium: Still Open Scenarios. Pathogens 2022;11:515. [DOI: 10.3390/pathogens11050515] [Reference Citation Analysis]
4 Diptyanusa A, Sari IP. Treatment of human intestinal cryptosporidiosis: A review of published clinical trials. Int J Parasitol Drugs Drug Resist 2021;17:128-38. [PMID: 34562754 DOI: 10.1016/j.ijpddr.2021.09.001] [Reference Citation Analysis]
5 Schneider A, Wendt S, Lübbert C, Trawinski H. Current pharmacotherapy of cryptosporidiosis: an update of the state-of-the-art. Expert Opin Pharmacother 2021;:1-6. [PMID: 34281461 DOI: 10.1080/14656566.2021.1957097] [Reference Citation Analysis]
6 Dhal AK, Panda C, Yun SI, Mahapatra RK. An update on Cryptosporidium biology and therapeutic avenues. J Parasit Dis 2022;:1-17. [PMID: 35755159 DOI: 10.1007/s12639-022-01510-5] [Reference Citation Analysis]
7 Castellanos-Gonzalez A, Sadiqova A, Ortega-Mendez J, White AC Jr. RNA-Based Therapy for Cryptosporidium parvum Infection: Proof-of-Concept Studies. Infect Immun 2022;:e0019622. [PMID: 35647663 DOI: 10.1128/iai.00196-22] [Reference Citation Analysis]
8 Kolářová I, Valigurová A. Hide-and-Seek: A Game Played between Parasitic Protists and Their Hosts. Microorganisms 2021;9:2434. [PMID: 34946036 DOI: 10.3390/microorganisms9122434] [Reference Citation Analysis]
9 Ryan U, Zahedi A, Feng Y, Xiao L. An Update on Zoonotic Cryptosporidium Species and Genotypes in Humans. Animals (Basel) 2021;11:3307. [PMID: 34828043 DOI: 10.3390/ani11113307] [Reference Citation Analysis]
10 Ryan UM, Feng Y, Fayer R, Xiao L. Taxonomy and molecular epidemiology of Cryptosporidium and Giardia - a 50 year perspective (1971-2021). Int J Parasitol 2021:S0020-7519(21)00296-4. [PMID: 34715087 DOI: 10.1016/j.ijpara.2021.08.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jumani RS, Blais J, Tillmann HC, Segal F, Wetty D, Ostermeier C, Nuber N, Lakshman J, Aziz N, Chandra R, Chen WH, Chappell CL, Diagana TT, Manjunatha UH. Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing Antiparasitic Agents. ACS Infect Dis 2021;7:959-68. [PMID: 33822577 DOI: 10.1021/acsinfecdis.1c00057] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Johansen ØH, Abdissa A, Bjørang O, Zangenberg M, Sharew B, Alemu Y, Moyo S, Mekonnen Z, Langeland N, Robertson LJ, Hanevik K. Oocyst Shedding Dynamics in Children with Cryptosporidiosis: a Prospective Clinical Case Series in Ethiopia. Microbiol Spectr 2022;:e0274121. [PMID: 35699433 DOI: 10.1128/spectrum.02741-21] [Reference Citation Analysis]